Feb 27 – Mar 2, 2019 | Marco Island, FL
Registration Open
ANDREW CLARK
CORNELL UNIVERSITY
KATHERINE S. POLLARD
UNIVERSITY OF CALIFORNIA,
SAN FRANCISCO
AVIV REGEV
BROAD INSTITUTE OF MIT AND HARVARD
TUULI LAPPALAINEN
NEW YORK GENOME CENTER
The cutting edge science, new applications, and access to true leaders always makes AGBT stand out.
— 2018 General Meeting AttendeeAGBT is a cornerstone in genomics and the most important meeting I attend all year.
— 2018 General Meeting AttendeeHigh level networking and discussion of hard core science and technology is why AGBT is exceptional.
— 2018 General Meeting AttendeeThe 2019 Agenda is coming soon
AGBT 2019 Registration is open
See the
ATTEND IF YOU ARE
Scientists
Clinicians
Geneticists
Oncologists
Commercial scientists
Business sector leaders
Researchers
Bioinformaticians
ALL STAKEHOLDERS INTERESTED IN ADVANCING THE INTERFACE OF GENOMICS, MEDICINE, AND HEALTH
ATTEND FOR
New discoveries in DNA and RNA sequencing technologies
Experimental and analytic approaches for genomic studies and applications
Clinical case studies Ground breaking research
The integration of genomics and pharmacogenomics to individualized patient care
Networking with top industry leaders
The Scientific
Organizing Committee
Penelope Bonnen, Baylor College of Medicine
Ken Dewar, McGill University and Genome Quebec Innovation Centre
Federica Di-Palma, Earlham Institute, University of East Anglia
Eric Green, National Human Genome Research Institute /National Institute of Health
Martin Hirst, University of British Columbia
Elaine Mardis, The Institute for Genomic Medicine at Nationwide Children’s Hospital
Christopher Mason, Weill Cornell Medicine
John McPherson, University of California Davis
Len Pennacchio, Lawrence Berkeley National Laboratory
Beth Shapiro, University of California Santa Cruz
Michael Zody, New York Genome Center